Skip to content

Main Navigation

Products
- Helios UV-C
  A three-part, patented UV-C disinfection system.
- PathTrac
  Identify, monitor, and enhance operating room
  infection prevention protocols
Healthcare Acute
Programs
Why Surfacide
Contact Us
Sign In
Spanish

Sign In

Certificates

ISO 13485:2016 MDSAP Certificate

BS 8626:2022 Compliant

View Certificate

Partner with the industry leader in UVC disinfection.

Partner With Us

Discover

Blog
Careers

Company

Contact Us
About Us
Distributors

Support

Open a Ticket
Frequently Asked Questions

Stay Connected

Email

Privacy Notice
Terms and Conditions
Patents
Certificates

The Surfacide Helios UV-C system has not been reviewed or approved by FDA and is marketed under FDA’s “Enforcement Policy for Sterilizers, Disinfectant Devices, and Air Purifiers During the Coronavirus Disease 2019 (COVID 19) Public Health Emergency.”

Intended Use: The Surfacide Helios UV-C system is a low-level disinfectant device which reduces, but does not completely eliminate, environmental microorganisms as an adjunct to currently existing cleaning practices and which is not a replacement for or modification to such practices.

UV-C energy absorbed by the genetic material (DNA/RNA) of the microorganisms causes a disruption of the nucleotide bonds and formation of thymidine dimers.

Surfacide Helios incorporates multiple emitters in unoccupied environments to disinfect non-porous surfaces up to a radius of seven (7) feet from each emitter and within direct line-of-sight. Cycle duration varies by area and is calculated based on laser mapping and defined energy level and distance threshold settings.

×

Search for:

×

English

Spanish English